Shermen WSC Acquisition Corp. (“Shermen” or the “Company”) engaged M.M. Dillon & Co. (“Dillon”) as its financial advisor in connection with the acquisition of the Westway division of ED&F Man.…
Founded by a team of pathologists and industry executives, PathCentral is executing upon a compelling IT-enabled pathology services business model. The PathCentral solution combines a web-based enterprise software platform with…
M.M. Dillon & Co. (“Dillon”) acted as exclusive financial advisor to National Patent Development Corporation (“NPDC”) on the sale of NPDC’s wholly owned subsidiary, Five Star Products, Inc. (“Five Star”…
General Motors Company ("GM" or the "Company") (NYSE:GM, TSX:GMM) recently announced the pricing of its initial public offering of 549,700,000 shares of Common Stock at $33.00 per share, generating gross…
M.M. Dillon & Co. (“Dillon”) was engaged to act as financial advisor to Takata Corporation (“Takata” or the “Company”) in connection with a possible acquisition of the automotive safety products…
Gypsii is a publicly traded company offering Location-based, social networking application for use with mobile devices to over 1 million users. M.M Dillon & Co. (“Dillon”) served as Gypsii’s sole…
MM Dillon acted as a placement agent for ContraFect Corporation in connection with its private placement of 4.73 million shares of common stock and warrants to purchase an additional 2.36…
Retained by Dechert for the Defendant MM Dillon represented The Bank of New York Mellon Trust Company for those who hold the senior debt of Momentive Performance Materials, as an…
Retained by Mintz Levin, acting on behalf of its client Oxbow Carbon LLC (“Oxbow”), and its control shareholder William Koch (the “Plaintiff”), MM Dillon acted as a qualified expert witness…
MM Dillon acted as a financial advisor to Valeritas Holdings, Inc. (NASDAQ:VLRX) in its underwritten public offering of 13,700,000 shares of its common stock at a public offering price of…